NP49425 Generic and Biosimilar Transition Medicines
Supply of generic and biosimilar transition medicines to NHS Scotland.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£234,969,011
Published
30 Mar 2026
Closes
22 Sept 2025
Procurement details
Source
Pcs
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)
£99,950,577
Supply of generic cand biosimilar transition medicines to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.
Delivery: Scotland
Lot 2 Cytokine Modulators (Omalizumab)
£15,643,757
Supply of cytokine modulators (omalizumab) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.
Delivery: Scotland
Lot 3 Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines
£26,183,523
Supply of gastrointestinal, endocrine, blood, and multiple sclerosis medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.
Delivery: Scotland
Lot 4 Denosumab (Osteoporosis) and Ferric Carboxymaltose
£27,420,432
Supply of denosumab (osteoporosis) and ferric carboxymaltose to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.
Delivery: Scotland
Lot 5 Apremilast
£1,495,958
Supply of apremilast to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.
Delivery: Scotland
Lot 6 Cardiovascular and Respiratory Medicines
£457,484
Supply of cardiovascular and respiratory medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.
Delivery: Scotland
Lot 7 Nintedanib
£27,322,496
Supply of nintedanib to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.
Delivery: Scotland
Lot 8 Cancer Medicines (Group 1)
£15,175,245
Supply of cancer medicines (group 1) to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.
Delivery: Scotland
Lot 9 Cancer Medicines (Group 2)
£21,258,752
Supply of cancer medicines (group 2) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.
Delivery: Scotland
Lot 10 Psychiatry and Neurology Medicines
£60,787
Supply of psychiatry and neurology medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.
Delivery: Scotland
Documents
Unlock document linkNP49425 Generic and Biosimilar Transition Medicines
Not provided
Supply of generic and biosimilar transition medicines to NHS Scotland.
Contract notice · Web page
NP49425 Generic and Biosimilar Transition Medicines
Not provided
Supply of generic and biosimilar transition medicines to NHS Scotland.
Award notice · Web page
NP49425 Generic and Biosimilar Transition Medicines
Not provided
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.